Drugs Home > Generic Afinitor

At this time, patents prevent the manufacturing of a generic version of Afinitor (everolimus). The first patent is scheduled to expire in July 2016, which would be the earliest date that a generic version could become available. However, lawsuits or other patents for new uses of the drug could change this date.

Can I Buy Generic Afinitor?

Afinitor® (everolimus) is a prescription medication that belongs to a group of drugs known as kinase inhibitors. It is approved to treat certain types of cancer and tumors. Specifically, Afinitor is approved for the treatment of:
  • Advanced tumors of the pancreas
  • Advanced kidney cancer after certain other medicines have been tried and failed
  • A rare type of brain tumor or certain kidney tumors in people with a genetic condition known as tuberous sclerosis
  • Certain types of advanced breast cancer in postmenopausal women who have not responded to certain other medications. 
Afinitor is made by Novartis Pharma Stein AG for Novartis Pharmaceuticals Corporation. Currently, the drug is protected by patents that prevent any generic versions from being sold in the United States.

When Will a Generic Version Be Available?

The first patent is set to expire in July 2016. This is the earliest predictable date that a generic version could become available. However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific Afinitor uses. Once the patent expires, there may be several companies that manufacture a generic Afinitor drug.

Is Everolimus a Generic Form of Afinitor?

No -- everolimus is the active ingredient in Afinitor, but is not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.